Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Guideline of transthyretin-related hereditary amyloidosis for clinicians

1 Jan 2013

Abstract excerpt

Transthyretin amyloidosis is a progressive and eventually fatal disease primarily characterized by sensory, motor, and autonomic neuropathy and/or cardiomyopathy. Given its phenotypic unpredictability and variability, transthyretin amyloidosis can be difficult to recognize and manage. Misdiagnosis is common, and patients may wait several years before accurate diagnosis, risking additional significant irreversible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Dermatological and Skeletal Disorders
Share to IgG4-Related and Inflammatory Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23425518
DOI: 10.1186/1750-1172-8-31

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 15 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Guideline of transthyretin-related hereditary amyloidosis for cliniciansPMID 23425518Read ↗

Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy ManagementSemantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.Semantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy–2025 Update: Current Diagnostic Approaches and Emerging Therapeutic OptionsSemantic proximity Read ↗

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progressionSemantic proximity Read ↗

Updates on hereditary transthyretin amyloidosis polyneuropathy.Semantic proximity Read ↗

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis overview.Semantic proximity Read ↗

Neuropathy Associated with Systemic Amyloidosis.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: a case report.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathySemantic proximity Read ↗

[Recommendations update for the diagnosis and treatment of transthyretin variant amyloidosis (ATTRv)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.